Hiroyuki Uchida (H Uchida)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 39

Top Topics

Cardiopulmonary Resuscitation

Systematic Review

Alcohol Use Disorder

Bipolar Disorder

Top Venues

Neuropsychopharmacology reports

Psychiatry and clinical neurosciences

Acta psychiatrica Scandinavica

Translational psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, Shinichiro Nakajima, Matthew M Nour, Robin Carhart-Harris, Hiroyuki Uchida
Development of the Japanese version of the Ego-Dissolution Inventory (EDI). Neuropsychopharmacology reports 44 (1) (2024)
Shuhei Shibukawa, Hirohito Kan, Shiori Honda, Masataka Wada, Ryosuke Tarumi, Sakiko Tsugawa, Yui Tobari, Norihide Maikusa, Masaru Mimura, Hiroyuki Uchida, Yuko Nakamura, Shinichiro Nakajima, Yoshihiro Noda, Shinsuke Koike
Alterations in subcortical magnetic susceptibility and disease-specific relationship with brain volume in major depressive disorder and schizophrenia. Translational psychiatry 14 (1) (2024)
Shuhei Shibukawa, Hirohito Kan, Shiori Honda, Masataka Wada, Ryosuke Tarumi, Sakiko Tsugawa, Yui Tobari, Norihide Maikusa, Masaru Mimura, Hiroyuki Uchida, Yuko Nakamura, Shinichiro Nakajima, Yoshihiro Noda, Shinsuke Koike
Alterations in subcortical magnetic susceptibility and disease-specific relationship with brain volume in major depressive disorder and schizophrenia. Translational psychiatry 14 (1) (2024)
Yohei Ohtani, Hideaki Tani, Kie Nomoto-Takahashi, Taisuke Yatomi, Kengo Yonezawa, Sota Tomiyama, Nobuhiro Nagai, Keisuke Kusudo, Shiori Honda, Sotaro Moriyama, Shinichiro Nakajima, Takashige Yamada, Hiroshi Morisaki, Yu Iwabuchi, Masahiro Jinzaki, Kimio Yoshimura, Tsuyoshi Eiro, Sakiko Tsugawa, Sadamitsu Ichijo, Yu Fujimoto, Tomoyuki Miyazaki, Takuya Takahashi, Hiroyuki Uchida
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial. Psychiatry and clinical neurosciences (2024)
Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, Shinichiro Nakajima, Matthew M Nour, Robin Carhart-Harris, Hiroyuki Uchida
Development of the Japanese version of the Ego-Dissolution Inventory (EDI). Neuropsychopharmacology reports (2024)
Shuhei Shibukawa, Hirohito Kan, Shiori Honda, Masataka Wada, Ryosuke Tarumi, Sakiko Tsugawa, Yui Tobari, Norihide Maikusa, Masaru Mimura, Hiroyuki Uchida, Yuko Nakamura, Shinichiro Nakajima, Yoshihiro Noda, Shinsuke Koike
Alterations in subcortical magnetic susceptibility and disease-specific relationship with brain volume in major depressive disorder and schizophrenia. Translational psychiatry 14 (1) (2024)
Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, Shinichiro Nakajima, Matthew M Nour, Robin Carhart-Harris, Hiroyuki Uchida
Development of the Japanese version of the Ego-Dissolution Inventory (EDI). Neuropsychopharmacology reports 44 (1) (2024)
Keisuke Kusudo, Hideaki Tani, Kengo Yonezawa, Shinichiro Nakajima, Matthew M Nour, Robin Carhart-Harris, Hiroyuki Uchida
Development of the Japanese version of the Ego-Dissolution Inventory (EDI). Neuropsychopharmacology reports 44 (1) (2024)
Hideaki Tani, Kengo Yonezawa, Keisuke Kusudo, Frederick S Barrett, Shinichiro Nakajima, Hiroyuki Uchida
Development of the Japanese version of the Challenging Experience Questionnaire. Neuropsychopharmacology reports (2024)
Sakiko Tsugawa, Shiori Honda, Yoshihiro Noda, Cassandra Wannan, Andrew Zalesky, Ryosuke Tarumi, Yusuke Iwata, Kamiyu Ogyu, Eric Plitman, Fumihiko Ueno, Masaru Mimura, Hiroyuki Uchida, Mallar Chakravarty, Ariel Graff-Guerrero, Shinichiro Nakajima
Associations Between Structural Covariance Network and Antipsychotic Treatment Response in Schizophrenia. Schizophrenia bulletin (2023)
Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Hiroyuki Uchida
Development of the Japanese version of the 30-item Mystical Experience Questionnaire. Neuropsychopharmacology reports (2023)
Yohei Ohtani, Fumihiko Ueno, Mitsuru Kimura, Sachio Matsushita, Masaru Mimura, Hiroyuki Uchida
Highly endorsed screening and assessment scales for alcohol problems: A systematic review. Neuropsychopharmacology reports (2023)
Daichi Sone, Alexandra L Young, Shunichiro Shinagawa, Sakiko Tsugawa, Yusuke Iwata, Ryosuke Tarumi, Kamiyu Ogyu, Shiori Honda, Ryo Ochi, Karin Matsushita, Fumihiko Ueno, Nobuaki Hondo, Akihiro Koreki, Edgardo Torres-Carmona, Wanna Mar, Nathan Chan, Teruki Koizumi, Hideo Kato, Keisuke Kusudo, Vincenzo de Luca, Philip Gerretsen, Gary Remington, Mitsumoto Onaya, Yoshihiro Noda, Hiroyuki Uchida, Masaru Mimura, Masahiro Shigeta, Ariel Graff-Guerrero, Shinichiro Nakajima
Disease Progression Patterns of Brain Morphology in Schizophrenia: More Progressed Stages in Treatment Resistance. Schizophrenia bulletin (2023)
Masataka Wada, Yoshihiro Noda, Yusuke Iwata, Sakiko Tsugawa, Kazunari Yoshida, Hideaki Tani, Yoji Hirano, Shinsuke Koike, Daiki Sasabayashi, Haruyuki Katayama, Eric Plitman, Kazutaka Ohi, Fumihiko Ueno, Fernando Caravaggio, Teruki Koizumi, Philip Gerretsen, Takefumi Suzuki, Hiroyuki Uchida, Daniel J Mueller, Masaru Mimura, Gary Remington, Anthony A Grace, Ariel Graff-Guerrero, Shinichiro Nakajima
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment. Molecular psychiatry 27 (7) (2022)
Takashi Tsujii, Hitoshi Sakurai, Hiroyoshi Takeuchi, Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida
Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data. Neuropsychopharmacology reports (2022)
Kensuke Nomura, Ryosuke Tarumi, Kazunari Yoshida, Mitsuhiro Sado, Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida
Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder. PloS one 16 (11) (2021)
Fumihiko Ueno, Sachio Matsushita, Sachiko Hara, Shunji Oshima, Sungwon Roh, Vijay A Ramchandani, Masaru Mimura, Hiroyuki Uchida
Influence of alcohol and acetaldehyde on cognitive function: findings from an alcohol clamp study in healthy young adults. Addiction (Abingdon, England) (2021)
Nobuyuki Nomura, Kohei Kitagawa, Ryuhei So, Fuminari Misawa, Masafumi Kodama, Hiroyoshi Takeuchi, Robert Bies, Thomas Straubinger, Christopher Banker, Yuya Mizuno, Masaru Mimura, Hiroyuki Uchida
Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study. Therapeutic advances in psychopharmacology 11 (2021)
Fumihiko Ueno, Hiroyuki Uchida, Mitsuru Kimura, Akira Yokoyama, Tomoko Yonemoto, Mitsuru Itoh, Yosuke Yumoto, Hideki Nakayama, Sachio Matsushita
Increasing trend in the prevalence of alcohol-sensitive individuals with alcohol use disorder over the past 40 years. Psychiatry and clinical neurosciences (2021)
Tomomi Nakahara, Sakiko Tsugawa, Yoshihiro Noda, Fumihiko Ueno, Shiori Honda, Megumi Kinjo, Hikari Segawa, Nobuaki Hondo, Yukino Mori, Honoka Watanabe, Kazuho Nakahara, Kazunari Yoshida, Masataka Wada, Ryosuke Tarumi, Yusuke Iwata, Eric Plitman, Sho Moriguchi, Camilo de la Fuente-Sandoval, Hiroyuki Uchida, Masaru Mimura, Ariel Graff-Guerrero, Shinichiro Nakajima
Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies. Molecular psychiatry (2021)
Keisuke Asano, Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida
Prescription patterns in patients with schizophrenia who discontinued long-acting injectable antipsychotics: A chart-review. Psychiatry and clinical neurosciences 75 (5) (2021)
Kie Takahashi, Ryoko Yamazawa, Takefumi Suzuki, Masaru Mimura, Hiroyuki Uchida
Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional study. Neuropsychopharmacology reports 40 (3) (2020)
Nobuhiro Nagai, Hideaki Tani, Kazunari Yoshida, Philip Gerretsen, Takefumi Suzuki, Saeko Ikai-Tani, Masaru Mimura, Hiroyuki Uchida
Drug Attitude, Insight, and Patient's Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey. Neuropsychiatric disease and treatment 16 (2020)
Kohei Kitagawa, Ryuhei So, Nobuyuki Nomura, Yuya Mizuno, Fuminari Misawa, Masafumi Kodama, Hiroyuki Uchida, Masaru Mimura, Hiroyoshi Takeuchi
Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J). PloS one 15 (6) (2020)
T Yatomi, T Uchida, Hiroyoshi Takeuchi, S Kuramochi, K Yoshimura, M Mimura, Hiroyuki Uchida
Prescription patterns of psychotropics in patients receiving synthetic glucocorticoids. Acta psychiatrica Scandinavica 142 (3) (2020)
Suzanne J Reeves, Julie Bertrand, Hiroyuki Uchida, Kazunari Yoshida, Yohei Otani, Mikail Ozer, Kathy Y Liu, Elvira Bramon, Robert Bies, Bruce G Pollock, Robert Howard
Towards safer risperidone prescribing in Alzheimer's disease. The British journal of psychiatry : the journal of mental science (2020)
Kamiyu Ogyu, Yoshihiro Noda, Kazunari Yoshida, Shin Kurose, Fumi Masuda, Yu Mimura, Hana Nishida, Eric Plitman, Ryosuke Tarumi, Sakiko Tsugawa, Masataka Wada, Takahiro Miyazaki, Hiroyuki Uchida, Ariel Graff-Guerrero, Masaru Mimura, Shinichiro Nakajima
Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia. Neuropsychopharmacology reports 40 (2) (2020)
Takuto Ishida, Kie Takahashi, Kazuhiro Sugiyama, Yuichi Hamabe, Masaru Mimura, Takefumi Suzuki, Hiroyuki Uchida
How common is pulmonary embolism compared to acute myocardial infarction among patients with severe mental illnesses? Psychiatry and clinical neurosciences 74 (4) (2020)
Hitoshi Sakurai, Masaki Kato, Norio Yasui-Furukori, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Ikuko Kishida, Yuka Sugawara Kikuchi, Toshiaki Kikuchi, Asuka Katsuki, Hiroyuki Uchida, null null
Pharmacological management of bipolar disorder: Japanese expert consensus. Bipolar disorders 22 (8) (2020)
Tomoyuki Miyazaki, Waki Nakajima, Mai Hatano, Yusuke Shibata, Yoko Kuroki, Tetsu Arisawa, Asami Serizawa, Akane Sano, Sayaka Kogami, Tomomi Yamanoue, Kimito Kimura, Yushi Hirata, Yuuki Takada, Yoshinobu Ishiwata, Masaki Sonoda, Masaki Tokunaga, Chie Seki, Yuji Nagai, Takafumi Minanimoto, Kazunori Kawamura, Ming-Rong Zhang, Naoki Ikegaya, Masaki Iwasaki, Naoto Kunii, Yuichi Kimura, Fumio Yamashita, Masataka Taguri, Hideaki Tani, Nobuhiro Nagai, Teruki Koizumi, Shinichiro Nakajima, Masaru Mimura, Michisuke Yuzaki, Hiroki Kato, Makoto Higuchi, Hiroyuki Uchida, Takuya Takahashi
Visualization of AMPA receptors in living human brain with positron emission tomography. Nature medicine 26 (2) (2020)
Takuto Ishida, Kazuki Miyazaki, Takahiro Yukawa, Toshinobu Yamagishi, Kazuhiro Sugiyama, Takahiro Tanabe, Yuichi Hamabe, Masaru Mimura, Takefumi Suzuki, Hiroyuki Uchida
Etiology of out-of-hospital cardiac arrest in psychiatric patients: Chart review. Psychiatry and clinical neurosciences 73 (5) (2019)
Fumihiko Ueno, Takefumi Suzuki, Shinichiro Nakajima, Sachio Matsushita, Masaru Mimura, Tomoyuki Miyazaki, Takuya Takahashi, Hiroyuki Uchida
Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies. Neuropsychopharmacology reports 39 (3) (2019)
Ryosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, Eric Plitman, Shiori Honda, Karin Matsushita, Sofia Chavez, Kyosuke Sawada, Masataka Wada, Mie Matsui, Shinya Fujii, Takahiro Miyazaki, M Mallar Chakravarty, Hiroyuki Uchida, Gary Remington, Ariel Graff-Guerrero, Masaru Mimura, Shinichiro Nakajima
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (4) (2019)
Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, Takefumi Suzuki, Masaru Mimura, Hiroyoshi Takeuchi
Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 45 (5) (2019)
Hideaki Tani, Mitsuhiro Tada, Takaki Maeda, Mika Konishi, Satoshi Umeda, Yuri Terasawa, Masaru Mimura, Takuya Takahashi, Hiroyuki Uchida
Comparison of emotional processing assessed with fear conditioning by interpersonal conflicts in patients with depression and schizophrenia. Psychiatry and clinical neurosciences 73 (3) (2018)
K Kubo, W W Fleischhacker, Takefumi Suzuki, N Yasui-Furukori, M Mimura, Hiroyuki Uchida
Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs. Acta psychiatrica Scandinavica 139 (2) (2018)
Yuhei Kikuchi, Joseph Zohar, Takefumi Suzuki, Masaru Mimura, Gohei Yagi, Hiroyuki Uchida
Mood stabilizers as an Achilles' heel for indication-based nomenclature and roles of Neuroscience-based Nomenclature. Psychiatry and clinical neurosciences 72 (12) (2018)
Hiroyuki Uchida
Neuroscience-based Nomenclature: What is it, why is it needed, and what comes next? Psychiatry and clinical neurosciences 72 (2) (2018)
Y Mizuno, Alex Hofer, B Frajo-Apor, F Wartelsteiner, G Kemmler, S Pardeller, T Suzuki, M Mimura, W W Fleischhacker, Hiroyuki Uchida
Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study. Acta psychiatrica Scandinavica 137 (4) (2017)